Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.81-0.16 (-1.46%)
At close: 04:00PM EST
11.00 +0.19 (+1.76%)
After hours: 07:42PM EST

AbCellera Biologics Inc.

2215 Yukon Street
Vancouver, BC V5Y 0A1
Canada

https://www.abcellera.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees475

Key executives

NameTitlePayExercisedYear born
Dr. Carl L.G. Hansen Ph.D.CEO, Pres & Chairperson616.66k2.77M1975
Mr. Andrew Booth M.B.A.Chief Financial Officer563.57k37.12M1974
Dr. Veronique Lecault Ph.D.COO & Director563.57k13.19M1985
Mr. Tryn T. Stimart Esq., J.D.Chief Legal Officer, Chief Compliance Officer & Corp. Sec.563.8k24.68M1970
Dr. Ester Falconer Ph.D.Chief Technology OfficerN/AN/A1975
Mr. Bo Barnhart Ph.D.Scientific DirectorN/AN/AN/A
Ms. Tiffany Chiu B.Sc., Ph.D.VP of CommunicationsN/AN/AN/A
Alexandra Weirich M.Sc.Mang. of Marketing & CommunicationsN/AN/AN/A
Graham Craig M.Sc.Director of Corp. Devel.N/AN/AN/A
Caitlin Webster CIPD, M.Sc.Sr. Mang. of People & CultureN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Corporate governance

AbCellera Biologics Inc.’s ISS governance QualityScore as of 1 February 2023 is 8. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 4; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.